Des-gamma-carboxy prothrombin (DCP) as a biomarker for treatment response in hepatocellular carcinoma.

被引：1
|
作者：
Conner, Elizabeth
Chang, Jeremy
Burgoyne, Adam
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
283-424-425; 613-3267-9109-8855-5546; 130-540-543-4790; 613-135-2370-5109; 298-145-222-184-4809; 5; 4; 3; 2; 1854; 182; 7; 6;
D O I：
10.1200/JCO.2024.42.3_suppl.547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [21] ALPHA-FETOPROTEIN AND DES-GAMMA-CARBOXY PROTHROMBIN ASSERUM MARKERS FOR HEPATOCELLULAR CARCINOMA
    Stojakovic, T.
    Putz-Bankuti, C.
    Scharnagl, H.
    Pock, H.
    Stauber, R. E.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S275 - S275
  • [22] SENSITIVITY OF DES-GAMMA-CARBOXY PROTHROMBIN TO VITAMIN-K IN HEPATOCELLULAR-CARCINOMA
    OKUDA, H
    NAKANISHI, T
    YOSHIDA, K
    FURUKAWA, M
    YAMAGATA, H
    AJIMA, T
    TOMIMATSU, M
    OBATA, H
    HEPATOLOGY, 1991, 14 (04) : A106 - A106
  • [23] Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
    Hakamada, Kenichi
    Kimura, Norihisa
    Miura, Takuya
    Morohashi, Hajime
    Ishido, Keinosuke
    Nara, Masaki
    Toyoki, Yoshikazu
    Narumi, Shunji
    Sasaki, Mutsuo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (09) : 1370 - 1377
  • [24] A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma
    Bertino, G.
    Ardiri, A. M.
    Boemi, P. M.
    Ierna, D.
    Interlandi, D.
    Caruso, L.
    Minona, E.
    Trovato, M. A.
    Vicari, S.
    Li Destri, G.
    Puleo, S.
    PANMINERVA MEDICA, 2008, 50 (03) : 221 - 226
  • [25] DES-GAMMA-CARBOXY (ABNORMAL) PROTHROMBIN AS A SERUM MARKER OF PRIMARY HEPATOCELLULAR-CARCINOMA
    LIEBMAN, HA
    FURIE, BC
    TONG, MJ
    BLANCHARD, RA
    LO, KJ
    LEE, SD
    COLEMAN, MS
    FURIE, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (22): : 1427 - 1431
  • [26] DES-GAMMA-CARBOXY (ABNORMAL) PROTHROMBIN AND HEPATOCELLULAR-CARCINOMA - A CRITICAL-REVIEW
    WEITZ, IC
    LIEBMAN, HA
    HEPATOLOGY, 1993, 18 (04) : 990 - 997
  • [27] The ratio of serum des-gamma-carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma
    Shimagaki, Tomonari
    Yoshizumi, Tomoharu
    Itoh, Shinji
    Iseda, Norifumi
    Tomiyama, Takahiro
    Morinaga, Akinari
    Wang, Huanlin
    Kurihara, Takeshi
    Nagao, Yoshihiro
    Toshima, Takeo
    Harada, Noboru
    Kinjo, Nao
    Maeda, Takashi
    Mori, Masaki
    HEPATOLOGY RESEARCH, 2022, 52 (04) : 381 - 389
  • [28] PRODUCTION OF ABNORMAL PROTHROMBIN (DES-GAMMA-CARBOXY PROTHROMBIN) BY HEPATOCELLULAR-CARCINOMA - A CLINICAL AND EXPERIMENTAL-STUDY
    OKUDA, H
    OBATA, H
    NAKANISHI, T
    FURUKAWA, R
    HASHIMOTO, E
    JOURNAL OF HEPATOLOGY, 1987, 4 (03) : 357 - 363
  • [29] An isoform of des-gamma-carboxy prothrombin (NX-PVKA) is a prognostic marker of hepatocellular carcinoma
    Takeji, Satoru
    Hirooka, Masashi
    Koizumi, Yohei
    Ochi, Hironori
    Tokumoto, Yoshio
    Tada, Fujimasa
    Abe, Masanori
    Onji, Morikazu
    Hiasa, Yoichi
    HEPATOLOGY, 2013, 58 : 1252A - 1252A
  • [30] Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells
    Gao, Fu-Jun
    Cui, Shu-Xiang
    Chen, Ming-Hui
    Cheng, Yan-Na
    Sun, Li-Rui
    Ward, S. G.
    Kokudo, Norihiro
    Tang, Wei
    Qu, Xian-Jun
    LIFE SCIENCES, 2008, 83 (23-24) : 815 - 820
12345